RxDoctor Payments Data

Ryan Tyner, PA

Physician Assistant · Memphis, TNNPI 1710583596

Payments from drug & device makers

$4,216in general payments, 2019–2025

Across 262 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$595
  • Pfizer$523
  • Philips North America LLC$498
  • Boehringer Ingelheim$452
  • Actelion Pharmaceuticals US, Inc.$444
  • Johnson & Johnson$351
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$4,19599%
  • Education$221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,216 in reported general payments places this provider in the 85th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$19,975
Medicare patients
173
Services billed
444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban75$69,574
JardianceEmpagliflozin38$30,814
XareltoRivaroxaban33$25,590
EntrestoSacubitril/Valsartan21$25,350
Repatha SureclickEvolocumab15$11,583
FarxigaDapagliflozin Propanediol13$8,322
Metoprolol Succinate197$2,330
Rosuvastatin Calcium170$2,118
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide52$1,714
Nebivolol Hcl16$1,618
Prasugrel Hcl22$1,568
Losartan Potassium120$1,299
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide55$1,257
Atorvastatin Calcium108$1,118
Amlodipine Besylate145$928

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$523$69,57475 claims
Boehringer IngelheimJardiance$452$30,81438 claims
Johnson & JohnsonXarelto$351$25,59033 claims
NovartisEntresto$595$25,35021 claims
AstraZenecaFarxiga$65$8,32213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →